Trailing-twelve-month (TTM) revenue is $346.90 Million with a year-over-year growth of +2.77%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $86,029,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $89,517,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-02 |
| Q1 FY2026Period ended 2026-03-31 | $86,842,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $84,511,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $346,899,000 |
Current P/S: $264,864,303 market capitalization ÷ $346,899,000 TTM revenue = 0.76x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $84.51M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:51:03.321Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Partner And Services | $49M | $65M | $73M | $80M | $85M | $87M |
| Subscription and Circulation | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas Excluding US | N/A | N/A | N/A | N/A | $16M | N/A |
| Americas Other | N/A | N/A |
$346.90M
$346.90 Million
+2.77%
vs. $337.55M a year ago (TTM)
+14.21%
5 Year compound annual growth rate
1 Year
+2.77%
3 Year
+5.91%
5 Year
+14.21%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $342.35M | +$9.42M | +2.83% |
| 2024 | $332.93M | +$23.53M | +7.61% |
| 2023 | $309.39M | +$30.32M | +10.86% |
| 2022 | $279.07M | +$59.22M | +26.94% |
| 2021 | $219.85M | +$67.49M | +44.29% |
| 2020 |
TTM Growth
+2.77%
3-Year CAGR
+5.91%
5-Year CAGR
+14.21%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T12:51:03.321Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $229M |
| $248M |
| $256M |
| Subscription And Circulation | $104M | $155M | N/A | N/A | N/A | N/A |
|---|
| N/A |
| $14M |
| N/A |
| N/A |
| Asia Pacific | $14M | $21M | $23M | $24M | $26M | $25M |
|---|
| E M E A | $12M | $21M | N/A | N/A | N/A | N/A |
|---|
| EMEA | N/A | N/A | $28M | $35M | $38M | $43M |
|---|
| Non Us | $5M | $9M | N/A | N/A | N/A | N/A |
|---|
| Non-US | N/A | N/A | $12M | N/A | N/A | N/A |
|---|
| Rest Of World | N/A | N/A | N/A | N/A | N/A | $16M |
|---|
| UNITED STATES | $121M | $170M | $217M | N/A | $253M | $259M |
|---|
| $152.37M |
| +$40.27M |
| +35.92% |
| 2019 | $112.10M | +$20.24M | +22.03% |
